Effect of Genetically Reduced Maternal Myostatin on Late Gestation Maternal, Fetal, and Placental Metabolomes in Mice
Myostatin (gene symbol: <i>Mstn</i>) is an autocrine and paracrine inhibitor of muscle growth. Pregnant mice with genetically reduced levels of myostatin give birth to offspring with greater adult muscle mass and bone biomechanical strength. However, maternal myostatin is not detectable...
Main Authors: | Ruth Opoku, Jenna DeCata, Charlotte L. Phillips, Laura C. Schulz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/6/719 |
Similar Items
-
Normal Placental Development and the Triad of Placental Dysfunction: The Maternal and Fetal Complications
by: Sathees B Chandra, et al.
Published: (2019-06-01) -
Maternal Supplementation with Ornithine Promotes Placental Angiogenesis and Improves Intestinal Development of Suckling Piglets
by: Yun Yang, et al.
Published: (2024-02-01) -
Dietary Folic Acid Supplementation Attenuates Maternal High-Fat Diet-Induced Fetal Intrauterine Growth Retarded via Ameliorating Placental Inflammation and Oxidative Stress in Rats
by: Huaqi Zhang, et al.
Published: (2023-07-01) -
Correlation of placental thickness with gestational age in second and third trimester using ultrasonography
by: Kshitija Narayan Vinchurkar, et al.
Published: (2023-09-01) -
Effects of Maternal Diabetes and Diet on Gene Expression in the Murine Placenta
by: Claudia Kappen, et al.
Published: (2022-01-01)